Table 3.
Final Risk Index Score
| Characteristic | Points |
|---|---|
| Age 40-49 | 4 |
| Age 50-64 | 6 |
| Age 65-74 | 6 |
| Age 75+ | 8 |
| Admission DX Level 2* | 2 |
| Admission DX Level 3* | 4 |
| Admission DX Level 4* | 5 |
| Fluoroquinolone Ever | 1 |
| 3rd/4th generation cephalosporin Ever | 2 |
| Lincosamide Ever | 1 |
| Past Hospital Visits | |
| 1 | 3 |
| 2+ | 5 |
| Alternative Model with LOS | |
| Age 40-49 | 8 |
| Age 50-64 | 12 |
| Age 65-74 | 12 |
| Age 75+ | 15 |
| LOS (days) | |
| 1 | 0 |
| 2-3 | 1 |
| 4-9 | 4 |
| 10+ | 8 |
| Fluoroquinolone Ever | 2 |
| 3rd/4th generation cephalosporin Ever | 3 |
| Lincosamide Ever | 1 |
| Past Hospital Visits | |
| 1 | 6 |
| 2+ | 8 |
*
Admission DX Level Based on Admission Diagnosis CCS Category. Diagnosis CCS Category definition provided in Table 4.